Li S - Search Results

1

Locoregional recurrence of pT3N0M0 breast cancer after mastectomy is not higher than that of pT1-2N0M0: an analysis for radiotherapy.

Sun JY, Wu SG, Li S, Li FY, Chen WF, Lin Q, He ZY. Sun JY, et al. Among authors: li s, li fy. Cancer Sci. 2013 May;104(5):599-603. doi: 10.1111/cas.12130. Epub 2013 Mar 29. Cancer Sci. 2013. PMID: 23421381 Free PMC article.

2

The significance of CO₂ combining power in predicting prognosis of patients with stage II and III colorectal cancer.

Li S, Zhu L, Cheng X, Wang Q, Feng J, Zhou J. Li S, et al. Biomark Med. 2019 Sep;13(13):1071-1080. doi: 10.2217/bmm-2018-0321. Epub 2019 Sep 9. Biomark Med. 2019. PMID: 31497992

3

Raltitrexed Chemotherapy Regimen Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer: A Prospective Multicenter Phase II Trial.

Li S, Li X, Zhu Q, Gao J, Zhu C, Zhu L. Li S, et al. Among authors: li x. Cancer Control. 2024 Jan-Dec;31:10732748241275012. doi: 10.1177/10732748241275012. Cancer Control. 2024. PMID: 39286935 Free PMC article. Clinical Trial.

4

Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy.

Li S, Zhu L, Yao L, Xia L, Pan L. Li S, et al. BMC Gastroenterol. 2014 Aug 29;14:154. doi: 10.1186/1471-230X-14-154. BMC Gastroenterol. 2014. PMID: 25175730 Free PMC article.

5

Development and validation of the chemotherapy-induced peripheral neuropathy integrated assessment - oxaliplatin subscale: a prospective cohort study.

Gu Z, Chen C, Gu J, Song Z, Wei G, Cai G, Shu Q, Zhu L, Zhu W, Deng H, Li S, Chen A, Yin Y, Wu Q, Zhu H, Li G, Dai A, Huo J. Gu Z, et al. Among authors: li s, li g. BMC Cancer. 2023 Nov 14;23(1):1109. doi: 10.1186/s12885-023-11541-7. BMC Cancer. 2023. PMID: 37964212 Free PMC article.

6

Development of a prognostic signature for esophageal cancer based on nine immune related genes.

Zhang Z, Chen C, Fang Y, Li S, Wang X, Sun L, Zhou G, Ye J. Zhang Z, et al. Among authors: li s. BMC Cancer. 2021 Feb 4;21(1):113. doi: 10.1186/s12885-021-07813-9. BMC Cancer. 2021. PMID: 33541291 Free PMC article.

7

Efficacy of Combined PD-1 Inhibitor and Bevacizumab in Unresectable Liver Metastasis of MSI-H Colorectal Cancer: A Case Report.

Wang Q, Zhong J, Wang Y, Bao J, Li S, Yang L. Wang Q, et al. Among authors: li s. Am J Case Rep. 2025 Jan 10;26:e946757. doi: 10.12659/AJCR.946757. Am J Case Rep. 2025. PMID: 39789783 Free PMC article.

8

Advances in Sn-Based Catalysts for Electrochemical CO₂ Reduction.

Zhao S, Li S, Guo T, Zhang S, Wang J, Wu Y, Chen Y. Zhao S, et al. Among authors: li s. Nanomicro Lett. 2019 Jul 29;11(1):62. doi: 10.1007/s40820-019-0293-x. Nanomicro Lett. 2019. PMID: 34138008 Free PMC article. Review.

9

Integrative characterization of G-Quadruplexes in the three-dimensional chromatin structure.

Hou Y, Li F, Zhang R, Li S, Liu H, Qin ZS, Sun X. Hou Y, et al. Among authors: li f, li s. Epigenetics. 2019 Sep;14(9):894-911. doi: 10.1080/15592294.2019.1621140. Epub 2019 Jun 10. Epigenetics. 2019. PMID: 31177910 Free PMC article.

10

Alternating modified CAPOX/CAPIRI plus bevacizumab in untreated unresectable metastatic colorectal cancer: a phase 2 trial.

Li S, Li X, Xu H, Huang J, Zhu J, Peng Y, Bao J, Zhu L. Li S, et al. Among authors: li x. Signal Transduct Target Ther. 2024 Dec 11;9(1):346. doi: 10.1038/s41392-024-02048-z. Signal Transduct Target Ther. 2024. PMID: 39658608 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100,642 results

Search Page

Filters